Overexpression of integrin-linked kinase promotes lung cancer cell migration and invasion via NF-κB-mediated upregulation of matrix metalloproteinase-9

International Journal of Medical Sciences

Volumn 10, Issue 8, 2013, Pages 995-1002

  Zhao, Mingjing ^a   Gao, Ying ^a   Wang, Lingling ^a   Liu, Shuo ^a   Han, Bing ^a   Ma, Lie ^a   Ling, Yuan ^a   Mao, Shitao ^a   Wang, Xiaoge ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Integrin linked kinase; Invasion; Lung cancer cell; Matrix metalloproteinase 9; Migration; Nuclear factor B

Indexed keywords

GELATINASE B; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN LINKED KINASE; TRANSCRIPTION FACTOR RELA;

ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LUNG CANCER; MOLECULAR PATHOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT;

INTEGRIN-LINKED KINASE; INVASION; LUNG CANCER CELL; MATRIX METALLOPROTEINASE-9; MIGRATION; NUCLEAR FACTOR-ΚB;

ANTIBODIES, NEUTRALIZING; BASE SEQUENCE; DNA PRIMERS; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84879286351     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5963     Document Type: Article

References (41)

1. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, et al. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature. 1996; 379: 91-6. doi:10.1038/379091a0.
2. Wu C, Dedhar S. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol. 2001; 155: 505-10. doi:10.1083/jcb.200108077. jcb.200108077 [pii].
3. Legate KR, Montanez E, Kudlacek O, Fassler R. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol. 2006; 7: 20-31. doi:nrm1789 [pii] 10.1038/nrm1789.
4. Troussard AA, Mawji NM, Ong C, Mui A, St -Arnaud R, Dedhar S. Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem. 2003; 278: 22374-8. doi:10.1074/jbc.M303083200 M303083200 [pii].
5. Hannigan G, Troussard AA, Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer. 2005; 5: 51-63. doi:nrc1524 [pii] 10.1038/nrc1524.
6. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A. 1998; 95: 11211-6.
7. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, et al. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci U S A. 2000; 97: 3207-12. doi:10.1073/pnas.060579697 060579697 [pii].
8. Bravou V, Klironomos G, Papadaki E, Stefanou D, Varakis J. Integrin-linked kinase (ILK) expression in human colon cancer. Br J Cancer. 2003; 89: 2340-1. doi:10.1038/sj.bjc.6601482 6601482 [pii].
9. Li R, Liu B, Yin H, Sun W, Yin J, Su Q. Overexpression of integrin-linked kinase (ILK) is associated with tumor progression and an unfavorable prognosis in patients with colorectal cancer. J Mol Histol. 2012. doi:10.1007/s10735-012-9463-6.
10. Ito R, Oue N, Zhu X, Yoshida K, Nakayama H, Yokozaki H, et al. Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma. Virchows Arch. 2003; 442: 118-23. doi:10.1007/s00428-002-0718-6.
11. Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW, et al. Integrin-linked kinase expression increases with prostate tumor grade. Clin Cancer Res. 2001; 7: 1987-91.
12. Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J Pathol. 2003; 201: 229-37. doi:10.1002/path.1441.
13. Dai DL, Makretsov N, Campos EI, Huang C, Zhou Y, Huntsman D, et al. Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival. Clin Cancer Res. 2003; 9: 4409-14.
14. Watzka SB, Setinek U, Stubenberger EB, Totsch M, Dekan G, Marcher M, et al. Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2011; 39: 180-4. doi:S1010-7940(10)00444-6 [pii] 10.1016/j.ejcts.2010.05.007.
15. Takanami I. Increased expression of integrin-linked kinase is associated with shorter survival in non-small cell lung cancer. BMC Cancer. 2005; 5: 1. doi:1471-2407-5-1 [pii] 10.1186/1471-2407-5-1.
16. Watzka SB, Rauscher-Potsch I, Stubenberger E, Getman V, Setinek U, Totsch M, et al. Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection. Eur J Cardiothorac Surg. 2010; 38: 254-9. doi:S1010-7940(10)00136-3 [pii] 10.1016/j.ejcts.2010.02.006.
17. Yu J, Shi R, Zhang D, Wang E, Qiu X. Expression of integrin-linked kinase in lung squamous cell carcinoma and adenocarcinoma: correlation with E-cadherin expression, tumor microvessel density and clinical outcome. Virchows Arch. 2011; 458: 99-107. doi:10.1007/s00428-010-1016-3.
18. Oneyama C, Morii E, Okuzaki D, Takahashi Y, Ikeda J, Wakabayashi N, et al. MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression. Oncogene. 2012; 31: 1623-35. doi:onc2011367 [pii] 10.1038/onc.2011.367.
19. Qian Y, Zhong X, Flynn DC, Zheng JZ, Qiao M, Wu C, et al. ILK mediates actin filament rearrangements and cell migration and invasion through PI3K/Akt/Rac1 signaling. Oncogene. 2005; 24: 3154-65. doi:1208525 [pii] 10.1038/sj.onc.1208525.
20. Mi Z, Guo H, Wai PY, Gao C, Kuo PC. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells. Carcinogenesis. 2006; 27: 1134-45. doi:bgi352 [pii] 10.1093/carcin/bgi352.
21. Woessner JF, Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991; 5: 2145-54.
22. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999; 13: 781-92.
23. Cakarovski K, Leung JY, Restall C, Carin-Carlson A, Yang E, Perlmutter P, et al. Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines. Int J Cancer. 2004; 110: 610-6. doi:10.1002/ijc.20135.
24. Patel BP, Shah SV, Shukla SN, Shah PM, Patel PS. Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck. 2007; 29: 564-72. doi:10.1002/hed.20561.
25. Passlick B, Sienel W, Seen-Hibler R, Wockel W, Thetter O, Mutschler W, et al. Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res. 2000; 6: 3944-8.
26. Zhu J, Pan X, Zhang Z, Gao J, Zhang L, Chen J. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells. Cell Signal. 2012; 24: 1323-32.
27. Matsui Y, Assi K, Ogawa O, Raven PA, Dedhar S, Gleave ME, et al. The importance of integrin-linked kinase in the regulation of bladder cancer invasion. Int J Cancer. 2012; 130: 521-31. doi:10.1002/ijc.26008.
28. Kang YS, Li Y, Dai C, Kiss LP, Wu C, Liu Y. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int. 2010; 78: 363-73. doi:ki2010137 [pii] 10.1038/ki.2010.137.
29. Kim YS, Sull JW, Sung HJ. Suppressing effect of resveratrol on the migration and invasion of human metastatic lung and cervical cancer cells. Mol Biol Rep. 2012; 39: 8709-16. doi:10.1007/s11033-012-1728-3.
30. Kao SJ, Su JL, Chen CK, Yu MC, Bai KJ, Chang JH, et al. Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-kappaB-mediated matrix metalloproteinase-9 expression. Toxicol Appl Pharmacol. 2012; 261: 105-15. doi:S0041-008X(12)00123-8 [pii] 10.1016/j.taap.2012.03.020.
31. Li Q, Zhang L, Han Y, Jiang Z, Wang Q. Propofol reduces MMPs expression by inhibiting NF-kappaB activity in human MDA-MB-231 cells. Biomed Pharmacother. 2012; 66: 52-6. doi:S0753-3322(11)00178-8 [pii] 10.1016/j.biopha.2011.10.006.
32. Wani AA, Jafarnejad SM, Zhou J, Li G. Integrin-linked kinase regulates melanoma angiogenesis by activating NF-kappaB/interleukin-6 signaling pathway. Oncogene. 2011; 30: 2778-88. doi:onc2010644 [pii] 10.1038/onc.2010.644.
33. Chen D, Zhang Y, Zhang X, Li J, Han B, Liu S, et al. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes. Acta Histochem. 2012. doi: S0065-1281(12)00076-1[pii] 10.1016/j.acthis.2012.05.004.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-8. doi:10.1006/meth.2001.1262 S1046-2023(01)91262-9 [pii].
35. Guo J, Verma UN, Gaynor RB, Frenkel EP, Becerra CR. Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit. Clin Cancer Res. 2004; 10: 3333-41. doi:10.1158/1078-0432.CCR-03-0366 10/10/3333 [pii].
36. Lokeshwar BL, Selzer MG, Zhu BQ, Block NL, Golub LM. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. Int J Cancer. 2002; 98: 297-309. doi:10.1002/ijc.10168 [pii].
37. Seftor RE, Seftor EA, De Larco JE, Kleiner DE, Leferson J, Stetler-Stevenson WG, et al. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin Exp Metastasis. 1998; 16: 217-25.
38. Li Y, Yang J, Dai C, Wu C, Liu Y. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest. 2003; 112: 503-16. doi:10.1172/JCI17913 112/4/503 [pii].
39. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest. 2001; 107: 241-6. doi:10.1172/JCI11991.
40. Maity G, Choudhury PR, Sen T, Ganguly KK, Sil H, Chatterjee A. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity. Tumour Biol. 2011; 32: 129-38. doi:10.1007/s13277-010-0106-9.
41. Baker RG, Hayden MS, Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metab. 2011; 13: 11-22. doi:S1550-4131(10)00450-X [pii] 10.1016/j.cmet.2010.12.008